Literature DB >> 3141269

Acquisition of cell-mediated immunity to Leishmania. II. LSH gene regulation of accessory cell function.

P M Kaye1, N K Patel, J M Blackwell.   

Abstract

The macrophage natural resistance gene. Lsh, regulates the ability of a selective population of tissue macrophages to control intracellular multiplication of Leishmania donovani by a T-cell independent mechanism. We show here, using mice congenic for Lsh, that this gene also contributes to the acquisition of T-cell-mediated immunity. Whereas both resistant and susceptible mice generate equivalent primary T-cell responses to infection, resistant mice show a rapid increase in accessory cell activity, allowing for greater subsequent T-cell expansion. This change in accessory cell function correlates with increased class II antigen expression relative to susceptible mice, both in vivo during early infection and in vitro in response to induction by interferon-gamma (IFN-gamma). Differences in vitro were independent of, but differentially affected by, amastigote infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141269      PMCID: PMC1385013     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Antigen presentation and the response to parasitic infection.

Authors:  P M Kaye
Journal:  Parasitol Today       Date:  1987-10

Review 2.  The basis for the immunoregulatory role of macrophages and other accessory cells.

Authors:  E R Unanue; P M Allen
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

Review 3.  Antigen-presenting function of the macrophage.

Authors:  E R Unanue
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

4.  A cell ELISA for the quantitation of leukocyte antigens. Requirements for calibration.

Authors:  H Baumgarten
Journal:  J Immunol Methods       Date:  1986-11-20       Impact factor: 2.303

5.  Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice.

Authors:  J Plant; A A Glynn
Journal:  Nature       Date:  1974-03-22       Impact factor: 49.962

6.  Inflammatory cells in murine visceral leishmaniasis express a dendritic cell marker.

Authors:  P M Kaye
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

7.  Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.

Authors:  H W Murray; H Masur; J S Keithly
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

8.  Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression.

Authors:  P M Kaye
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

9.  Regulation of I-A expression by murine peritoneal macrophages: differences linked to the Bcg gene.

Authors:  B S Zwilling; L Vespa; M Massie
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

10.  Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products.

Authors:  N E Reiner; W Ng; W R McMaster
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

View more
  11 in total

1.  Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice.

Authors:  M Roberts; J Alexander; J M Blackwell
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Antigen presentation by macrophages from bacille Calmette-Guérin (BCG)-resistant and -susceptible mice.

Authors:  M E Hilburger; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

3.  Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.

Authors:  A Alcaïs; L Abel; C David; M E Torrez; P Flandre; J P Dedet
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

4.  Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation.

Authors:  T Lang; E Prina; D Sibthorpe; J M Blackwell
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.

Authors:  T I Roach; A F Kiderlen; J M Blackwell
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis.

Authors:  J C Antoine; C Jouanne; T Lang; E Prina; C de Chastellier; C Frehel
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release.

Authors:  S Formica; T I Roach; J M Blackwell
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

8.  Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro.

Authors:  P M Kaye; G J Bancroft
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function.

Authors:  Carmel B Stober; Sven Brode; Jacqueline K White; Jean-François Popoff; Jenefer M Blackwell
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

10.  Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.

Authors:  Brima M Younis; Mohamed Osman; Eltahir A G Khalil; Francesco Santoro; Simone Furini; Rebecca Wiggins; Ada Keding; Monica Carraro; Anas E A Musa; Mujahid A A Abdarahaman; Laura Mandefield; Martin Bland; Toni Aebischer; Rhian Gabe; Alison M Layton; Charles J N Lacey; Paul M Kaye; Ahmed M Musa
Journal:  Mol Ther       Date:  2021-03-27       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.